Clinical Trial Update: Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder [Phase 2]

View source ↗

Summary

Completed Phase 2 dose-escalation trial evaluating propiverine hydrochloride in children with overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Propiverine hydrochloride (propiverine)

Snippet

Sponsor: APOGEPHA Arzneimittel GmbH | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED